Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure
A Prospective Interventional Study to Examine the Effectiveness of Anal Enlargement by Dilators as a Therapeutic Physical Tool in Acute Anal Fissure
1 other identifier
interventional
75
0 countries
N/A
Brief Summary
The treatment of anal fissure is mainly surgical. There are complications to this treatment, including damage to the inner anal sphincter and the appearance of fecal incontinence. Anal dilators are devices that allow gradual enlargement of the anus. To date, the use of these dilators has been in cases of sphincter scarring after a surgical procedure that has caused emptying difficulties. Only recently has the use of anal dilators been tried as a treatment for acute anal fissure. The study is designated to examine whether healing of the fissure can be achieved by conservative treatment with anal extensions and obviating the need for surgical treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2021
CompletedFirst Posted
Study publicly available on registry
April 2, 2021
CompletedStudy Start
First participant enrolled
May 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2022
CompletedApril 2, 2021
March 1, 2021
1 year
March 24, 2021
April 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Full recovery
The incidence of patients who achieved a full recovery of fissure at the end of treatment period
4 weeks
Secondary Outcomes (2)
Normal defecation
4 weeks
Quality of life
4 weeks
Study Arms (3)
research
EXPERIMENTALThe subjects in the study group will undergo a series of 4 treatments by 2 certified physiotherapists for pelvic floor treatment that will include instruction in self-use of anal dilators once a week for four weeks. The anal dilation will be performed using Dilatan® anal dilators (Enterprises Sapimed, Alessandria) in varying sizes of 22, 23 and 27 mm. In the first week, a 20 mm dilator will be inserted twice a day for at least 10 minutes. In the second week, a 23 mm extender will be inserted into the anus, twice a day for at least 10 minutes. In the last two weeks, a 27 mm extender will be inserted twice a day for at least 10 minutes. To facilitate the insertion of the extender, patients will use lubricating cream. At the end of each week, patients will meet with a pelvic floor physiotherapist to make sure that the insertion is done properly, that there are no side effects and that it is possible to move on to the next step.
waiting
NO INTERVENTIONThe subjects in the waiting group will be able after a month to choose to undergo surgery or also receive treatment by extenders.
surgery
ACTIVE COMPARATORThe subjects in the surgery group will undergo surgical treatment only.
Interventions
lateral internal sphincterotomy is a firmly established method for treating anal fissures.
Eligibility Criteria
You may qualify if:
- age 18-85 years
- Must have anal pain during bowel movements
- Must have acute posterior anal fissure
- Must have candidacy for surgery after failure of conservative treatment, or recurrence of the problem.
You may not qualify if:
- Concomitant anal pathology (anorectal fistulae,abscesses).
- Previous surgery on the pelvic floor.
- Inflammatory bowel disease
- Inability to sign consent to participate in the study
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Dan Carter
Sheba Medical Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2021
First Posted
April 2, 2021
Study Start
May 1, 2021
Primary Completion
May 1, 2022
Study Completion
September 1, 2022
Last Updated
April 2, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share